Clinical Trial Update: A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Healthy Adults [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating safety and immune response of the Novartis meningococcal ACWY vaccine in healthy adults. The study is completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Infections
• Meningococcal Meningitis

Drugs mentioned

• Menveo (meningococcal group A, C, W-135 and Y conjugate vaccine)

Snippet

Sponsor: Novartis Vaccines | Conditions: Meningococcal Meningitis, Meningococcal Infections | Phase 3 | Status: COMPLETED | Results posted: 2010-08-04